About Creyon Bio
Creyon Bio is a company based in San Diego (United States) founded in 2019 by Swagatam Mukhopadhyay.. Creyon Bio offers products and services including Oligonucleotide-Based Medicines and ASO Therapy. Creyon Bio operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Senti Biosciences, among others.
- Headquarter San Diego, United States
- Founders Swagatam Mukhopadhyay
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Creyon Bio India Private Limited
- Date of Incorporation 19 May, 2023
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
ARE
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Creyon Bio
Creyon Bio offers a comprehensive portfolio of products and services, including Oligonucleotide-Based Medicines and ASO Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-engineered medicines for precise gene-centric disease treatment.
Therapy targeting genes to minimize off-target effects in diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Creyon Bio
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Seed - Creyon Bio | Valuation | DCVC , Lux Capital | |
| Mar, 2022 | Amount | Series A - Creyon Bio | Valuation | DCVC , Lux Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Creyon Bio
Creyon Bio has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, DCVC and Lux Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Creyon Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Creyon Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Creyon Bio Comparisons
Competitors of Creyon Bio
Creyon Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Senti Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Creyon Bio
Frequently Asked Questions about Creyon Bio
When was Creyon Bio founded?
Creyon Bio was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Creyon Bio located?
Creyon Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
What does Creyon Bio do?
Creyon Bio was founded in 2019 in San Diego, United States, within the biotechnology sector. A platform for drug design and oligonucleotide-based drug development is offered. Proprietary machine-learning and AI models are employed to create medicines targeting rare or common diseases. Operations focus on advancing therapeutic solutions through computational methods in the pharmaceutical industry.
Who are the top competitors of Creyon Bio?
Creyon Bio's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Creyon Bio offer?
Creyon Bio offers Oligonucleotide-Based Medicines and ASO Therapy.
Who are Creyon Bio's investors?
Creyon Bio has 5 investors. Key investors include ARE, DCVC, Lux Capital, Casdin Capital, and BioBrit.